IREHF (Integrated Research) Current Deferred Revenue: $0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IREHF Integrated Research Ltd IREHF
54 GF Score
Price $0.20
GF Value $0.22
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Integrated Research Current Deferred Revenue?

Integrated Research IREHF 54 Current Deferred Revenue is $0.00 Mil as of Dec. 2025. GuruFocus rates IREHF with a GF Score™ of 54/100 and a GF Value™ of $0.22 (Fairly Valued). The stock has 4 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Integrated Research's current deferred revenue for the quarter that ended in Dec. 2025 was $0.00 Mil.

Integrated Research Current Deferred Revenue Related Terms


Integrated Research Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Integrated Research's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integrated Research Current Deferred Revenue Chart

Integrated Research Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.87 9.92 9.30 9.24 7.51

Integrated Research Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 9.24 0.00 7.51 0.00
IREHF
54GF Score
Integrated Research Ltd IREHF
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of $0.00 Mil mean?
Integrated Research (IREHF) has a Current Deferred Revenue of $0.00 Mil as of Dec. 2025. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Integrated Research and its competitors.
Is Integrated Research's Current Deferred Revenue too high?
Integrated Research's current Current Deferred Revenue is $0.00 Mil. Overall, Integrated Research has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Integrated Research's Current Deferred Revenue compare to UBER and SHOP?
Integrated Research's Current Deferred Revenue of $0.00 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Software company?
A good Current Deferred Revenue depends on the Software industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Integrated Research and its competitors. Integrated Research's current Current Deferred Revenue is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integrated Research stock overvalued right now?
Based on GuruFocus' analysis, Integrated Research (IREHF) is currently considered Fairly Valued. The stock's GF Value™ is $0.22, compared to a current price of $0.20 — trading 9.1% below its estimated fair value. The current Current Deferred Revenue is $0.00 Mil. Integrated Research's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Integrated Research (IREHF), the current Current Deferred Revenue is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integrated Research (IREHF) Overvalued in 2026?

Based on GuruFocus' analysis, Integrated Research stock appears to be undervalued. The current stock price of $0.20 is trading 9.1% below its estimated GF Value™ of $0.22. GuruFocus considers Integrated Research to be Fairly Valued.

Key valuation signals for IREHF:

  • Current Deferred Revenue: $0.00 Mil
  • GF Value™: $0.22 vs. price of $0.20 (9.1% below fair value)
  • GF Score™: 54/100 with 4 warning signs

No single metric tells the full story. See the IREHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Integrated Research Business Description

Other Exchanges IRI:Australia
Address 420 George Street, Suite 9.03, Level 9, Sydney, NSW, AUS, 2000
Integrated Research Ltd is engaged in the design, development, implementation, and sale of systems and applications management computer software for business-critical computing, Unified Communication networks, and Payment networks. Its Prognosis platform is an integrated suite of monitoring and management software, designed to give its clients, an operational insight into and optimize the operation of their HP NonStop, distributed system servers, Unified Communications (UC), Payment environments, and the business applications that run on these platforms. The company's geographic segments include Asia Pacific, Americas, and Europe. It generates revenue from licence fees, maintenance fees, subscription fees, testing solution services, and professional services.
54GF Score

Get the complete analysis for IREHF

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.20
Price
$0.22
GF Value